The Radiologist's Approach to Assessing Cancer Risk of Thyroid Nodul…

Penn Medicine

J. Langer

Less is More: Active Surveillance In Low-Risk Papillary Thyroid Canc…

Keck School of Medicine of USC

R. Michael Tuttle

ASCO® 2024 H&N Highlights: "Key Trial Updates in H&N Cancers"

2024 ASCO® Annual Meeting Insights Hub

N. Saba

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Oncologists' Perspectives on the Effects of Time Toxicity in Cancer …

Safiya Karim

ASCO® 2024 Summary: "News in Head&Neck Cancers"

2024 ASCO® Annual Meeting Insights Hub

P. Bossi

ESMO 2024 Summary: Head & Neck Cancer Take Home Messages

2024 ESMO Annual Meeting Insights Hub

P. Bossi

ACP 2024 Insights: Cancer of Unknown Primary

Insights from 2024 ACP Annual Meeting

S. Brondfield

ESMO 2024 Summary: Head & Neck Cancer Highlights

2024 ESMO Annual Meeting Insights Hub

N. Saba

Year in Review: Precision Medicine

Vivek Subbiah

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Is It Possible? Thyroglobulin as a Tumor Marker after Lobectomy for …

Keck School of Medicine of USC

T. Angell

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

Parathyroid Disease and Tumors

Yale Cancer Center

C. Gibson

Palliative Medicine in Cancer Patients

Houston Methodist

E. De Leon

Hypercalcaemia & Hypocalcaemia

Obafemi Awolowo University

D. Soyoye

ESMO 2024 Insights: 3-Weekly vs. Weekly Cisplatin in High-Risk HNSCC…

2024 ESMO Annual Meeting Insights Hub

M. Tahara

The Future of Lung Cancer Care

Yale Cancer Center

M. Davies

The Approach to a Patient with a Thyroid Nodule: Updating "The Bethe…

Penn Medicine

Z. Baloch